Use of Anti – VEGF Therapy for ROP: When and How

Related

• 

  Durability of Combination Therapy of Sozinibercept, an Anti-VEGF-C/D 'Trap' With Ranibizumab in nAMD or Aflibercept in DME

  Nathan C. Steinle, MD

  Annual Meeting Talks

  2024

• 

  Ferhina Ali Last Word

  Ferhina S Ali, MD, MPH

  Annual Meeting Talks

• 

  Prophylactic Intraocular Pressure–Lowering Measures in Antivascular Endothelial Growth Factor Therapy: Systematic Review and Meta-Analysis

  Parnian Arjmand, MD, MSc, FRCSC, DABO

  Annual Meeting Talks

  2022